0001654954-19-002459.txt : 20190308 0001654954-19-002459.hdr.sgml : 20190308 20190308105200 ACCESSION NUMBER: 0001654954-19-002459 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190306 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20190308 DATE AS OF CHANGE: 20190308 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SCIENTIFIC INDUSTRIES INC CENTRAL INDEX KEY: 0000087802 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 042217279 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-06658 FILM NUMBER: 19667995 BUSINESS ADDRESS: STREET 1: 70 ORVILLE DR STREET 2: AIRPORT INTERNATIONAL PLZ CITY: BOHEMIA STATE: NY ZIP: 11716 BUSINESS PHONE: 6315674700 MAIL ADDRESS: STREET 1: 70 ORVILLE DR CITY: BOHEMIA STATE: NY ZIP: 11716 8-K 1 form8k.htm PRIMARY DOCUMENT Blueprint
 
 
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________
 
FORM 8-K
_________________________________________________
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported):
March 6, 2019
_________________________________________________
 
SCIENTIFIC INDUSTRIES, INC.
_________________________________________________
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
 
000-6658
 
04-2217279
(State or other Jurisdiction)
 
(Commission File Number)
 
(IRS Employer No.)
 
 
80 Orville Drive
Bohemia, New York 11716
__________________________________________________
(Address of principal executive offices)
 
 
(631) 567-4700
__________________________________________________
(Registrant's telephone number, including area code)
 
 
Not Applicable
__________________________________________________
(Former name or former address, if changed since last report)
 
 
 
 
 
 
 
 
 
 
ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
 
The Company has entered into a consulting agreement through August 31, 2019 with Mr. John A. Moore, who has been a Director of the Company since January 23, 2019. The agreement provides for consulting services as to the operations of Scientific Bioprocessing, Inc., a wholly-owned subsidiary of the Company at a monthly fee of $10,000 plus the issuance of stock options valued at $3,000. The agreement may be renewed at the end of the term by mutual consent and incorporates non-competition and confidentiality clauses.
 
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
 
On March 6, 2019, the Board of Directors of the Company appointed Marcus Frampton to the Board of Directors as a Class B Director.
 
Mr. Frampton, age 39, is currently the Chief Investment Officer of the Alaska Permanent Fund Corporation, a $65 billion state sovereign wealth fund.  He also serves on the Board of Directors of Twin Creeks Timber, LLC and Rapid Partners, L.P.  At the Alaska Permanent Fund Corporation, Mr. Frampton also served as Director of Investments, Real Assets and Absolute Return from 2016 to 2018 and Director of Investments, Private Markets from 2012 to 2016.  He was Finance Lead, Strategic Investments at LPL Financial (Nasdaq: LPLA), an investment and wealth management services firm, from 2010-2012.  He was Associate/Vice President at PCG Capital Partners, a private equity firm, from 2005 to 2010.  Mr. Frampton holds a B.A. in Business-Economics from the University of California, Los Angeles.
 
ITEM 9.01 Financial Statements and Exhibits
 
(a) and (b) not applicable
 
(c) Exhibits
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SIGNATURE
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
SCIENTIFIC INDUSTRIES, INC.
 
 
 
 
 
 
 
 
Date: March 8, 2019
By:
/s/ Helena R. Santos
 
 
 
Helena R. Santos,
 
 
 
President and Chief Executive Officer
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EX-10 2 mooreagreement.htm MATERIAL CONTRACTS Blueprint
 
 CONSULTING AGREEMENT
 
 
Consulting Agreement, dated as of March 1, 2019 (this “Agreement”), between Scientific Industries Inc., a Delaware Corporation (the “Company”), and John A. Moore (“Moore”).
 
WHEREAS, Moore has been a Director of the Company since January 23, 2019;
 
WHEREAS, the Company desires that commencing with the date hereof, Moore be available to provide consulting services as to the operations of the Company and of Scientific Bioprocessing Inc. (“SBI”), principally with respect to the business development and strategy of SBI, and Moore desires to make himself available to provide such services on a timely basis at the reasonable request of the Company.
 
NOW THEREFORE, IT IS HEREBY AGREED as follows:
 
1. Moore agrees at the reasonable request of the Chief Executive Officer of the Company or such other officer of the Company designated by the Board of Directors of the Company, to advise and consult with such officer or an employee of the Company designated by such officer as to the operations of the Company and of SBI, including, but not limited to strategy, planning, administration, sales, operations, etc., as to SBI.
 
2. In no event shall Moore be required to perform any consulting services as to which he reasonably and timely objects based on location, period or nature of the services requested.
 
3. Subject to the prior written approval of the Chief Executive Officer of the Company, Moore is authorized to incur on behalf of the Company reasonable and necessary expenses in connection with the performance of his services on behalf of the Company or SBI hereunder, it being understood that he is not entitled to receive any health, pension or other benefits provided or made available to employees of the Company or of SBI.
 
4. For each full month that services are provided, the Company shall pay or cause SBI to pay Moore a fee of $10,000 in cash and issue to Moore that number of stock options with a grant date fair value of $3,000 as measured using the Black-Scholes option pricing model. The options shall be issued in accordance with the terms and conditions set forth in the Company’s 2012 Stock Option Plan. Such compensation shall be pro-rated for services provided for a partial month. Moore shall submit to the Chief Executive Officer of the Company a written report by the third business day following the end of each calendar month during the Term as to the number of hours he provided consulting services and a brief description of the services or matters for which he rendered consulting services, and the description of the out-of-pocket expenses incurred pursuant to Paragraph 3 hereof. The Company shall pay or cause SBI to pay Moore upon receipt of his invoice the fees and expenses set forth therein which were incurred for the services provided pursuant to this Agreement.
 
5. None of the consulting services to be performed pursuant to this Agreement shall include the services or time Moore provides as or in connection with his duties as a Director of the Company or a Director of SBI.
 
6. The services being provided hereunder shall be provided by Moore in his capacity as an independent contractor.
 
7. The “Term” of this Agreement shall be the six-month period ending August 31, 2019, unless terminated earlier by written notice by the Company or Moore delivered to the other. At the end of the Term, this Agreement may be renewed by the mutual written agreement of the parties hereto.
 
8. Consultant agrees to execute and deliver to the Company the Confidentiality Information Agreement and Non-Competition Agreement, in the form of Exhibits A and B attached hereto which agreements shall survive the expiration or termination of this Agreement for whatever reason.
 
9. This Agreement shall be deemed to have been made in the State of New York and shall be governed by and construed in accordance with the laws of the State of New York without regard to conflict of law rules thereof.
 
10. If any restriction contained in this Agreement shall be deemed to be invalid, illegal, or unenforceable by reason of the extent, duration, or geographical scope thereof, or otherwise, then the court making such determination shall have the right to reduce such extent, duration, geographical scope, or other provisions hereof, and in its reduced form such restriction shall then be enforceable in the manner contemplated hereby
 
 
 

 
 
 SCIENTIFIC INDUSTRIES, INC.
 
 
/s/ John A. Moore
 
 
/s/ Helena R. Santos
 
John A. Moore
 
 
Helena R. Santos
 

 
 
President and Chief Executive Officer

 

 

 
233495
 
 
 
Exhibit A
 
Confidential Information Agreement
 
 
February 28, 2019
 
 
Dear John:
 
This letter, when executed by the parties hereto, will constitute an agreement between Scientific Industries, Inc., a Delaware corporation (the "Company"), with its principal office in Bohemia, New York and which owns the outstanding capital stock of Scientific Bioprocessing, Inc., a Delaware Corporation (“SBI”), and John A. Moore ("Consultant") with respect to certain aspects of their continuing consulting relationship under the terms and conditions set forth below.
 
1.           The Company has engaged Consultant to perform principally on behalf of SBI, consulting services and Consultant desires to perform such services, as set forth in a separate agreement (the "Consulting Agreement"), during the period set forth in the Consulting Agreement (the “Term of Engagement”). As an inducement to the Company to engage Consultant as aforesaid, the parties hereto set forth the following additional terms and conditions.
 
2.           (a)           During and after the Term of Engagement, Consultant will not, directly or indirectly, disclose to any person, or use or otherwise exploit for the benefit of Consultant or for the benefit of anyone other than the Company or SBI, any Confidential Information (as defined below). Consultant shall have no obligation hereunder to keep confidential any Confidential Information if and to the extent disclosure is specifically required by law; provided, however, that in the event disclosure is required by applicable law, Consultant shall provide the Company or SBI, as the case may be, with prompt notice of such requirement, prior to making any disclosure, so that the Company or SBI may seek an appropriate protective order.
 
(b)           At the request of the Company, Consultant agrees to deliver to the Company or SBI, as the case may be, at any time during the Term of Engagement, or thereafter if secured later, all Confidential Information which Consultant may possess or control. Consultant agrees that all Confidential Information of the Company or SBI (whether now or hereafter existing) conceived, discovered or made by Consultant during the Term of Engagement exclusively belongs to the Company or SBI, as the case may be (and not to Consultant). Consultant will promptly disclose such Confidential Information to the Company or SBI, as the case may be, and perform all actions reasonably requested by the Company or SBI to establish and confirm such exclusive ownership. “Confidential Information” means any confidential information including, without limitation, any patent, patent application, copyright, trademark, trade name, service mark, service name, "know-how", trade secrets, customer lists, vendor lists, accounting records and other financial information, customer pricing and or terms, details of client or consultant contracts, pricing policies, cost information, operational methods, marketing plans or strategies, product development techniques or plans, business acquisition plans or any portion or phase of any business, scientific or technical information, ideas, discoveries, designs, computer programs (including source or object codes), processes, procedures, formulae, improvements, information relating to the products currently being sold, developed or contemplated, by the Company or its subsidiaries, including SBI (collectively, the “Company Group”), or which hereinafter may be sold, developed or contemplated, by a member of the Company Group through the date of termination of the Term of Engagement, including, but not limited to, bioprocessing products, mixers, including vortex mixers, rotating, catalytic research instruments, balances, scales, moisture analyzers, force gauges, shaking or oscillating apparatus; thermoelectric apparatus; or any industrial or laboratory processes, apparatus or equipment relating thereto (the “Products”) or other proprietary or intellectual property of the Company Group members whether or not in written or tangible form, and whether or not registered, and including all memoranda, notes, summaries, plans, reports, records, documents and other evidence thereof. The term “Confidential Information” does not include, and there shall be no obligation hereunder with respect to, information that becomes generally available to the public other than as a result of a disclosure by Consultant not permissible hereunder.
 
3.           Consultant agrees to indemnify and save the Company and SBI, their respective directors, officers, stockholders, agents, representatives, employees and consultants (and such persons' respective affiliates) harmless from any and all loss, damage, claims, liabilities, judgments and other cost and expense of every kind and nature which may be incurred by such persons by reason of the transactions contemplated by the Consulting Agreement or this letter agreement or the breach of any representation, warranty, covenant or agreement contained or refined to therein or herein (including, without limitation, reasonable attorneys' fees and expenses), except in the case of such person’s own willful default or gross negligence.
 
4.           The covenants, agreements, representations, and warranties contained in or made pursuant to this letter agreement shall survive termination of Consultant's engagement, irrespective of any investigation made by or on behalf of any party. If any restriction contained in this letter agreement shall be deemed to be invalid, illegal, or unenforceable by reason of the extent, duration, or geographical scope thereof, or otherwise, then the court making such determination shall have the right to reduce such extent, duration, geographical scope, or other provisions hereof, and in its reduced form such restriction shall then be enforceable in the manner contemplated hereby.
 
5.           This letter agreement shall be deemed to have been made in the State of New York and shall be governed by and construed in accordance with the laws of the State of New York without regard to conflict of law rules thereof. Any action, suit or proceeding arising out of, or in connection with, this letter agreement shall be adjudicated in a court of competent jurisdiction located in Nassau or Suffolk County, State of New York. The parties hereto unconditionally waive any right to a trial by jury and any objection which either of them may now or hereafter have to the establishment of venue as aforementioned or that any action, suit or proceeding has been brought in an inconvenient forum.
 
If Consultant is in agreement with the foregoing, please execute two copies of this letter in the space provided below and return them to the undersigned.
 
 
Very truly yours,
 
 
 
 
Scientific Industries, Inc.
 
 
 
 
 

By:  
/s/ Helena R. Santos
 
 
 
Helena R. Santos
 
 
 
President and Chief Executive Officer
 
 
 
 
 
 

 
 
 
AGREED AND ACCEPTED TO:
 
 
 
 
 

By:  
/s/ John A. Moore
 
 
 
John A. Moore
 
 
 

 



 
  
 
 
 
 
 
                                                          Exhibit B
Non-Competition Agreement
 
 
February 28, 2019
 
 
Dear John:
 
This letter, when executed by the parties hereto, will constitute an agreement between John A. Moore ("Consultant") and Scientific Industries, Inc., a Delaware corporation (the “Company”), on behalf of itself and its subsidiaries including Scientific Bioprocessing, Inc., a Delaware corporation (“SBI”, the Company, SBI and the subsidiaries of the Company collectively, the “Company Group”), with respect to certain aspects of your continuing relationship with members of the Company Group, under the terms and conditions set forth below.
 
1.           The Company has engaged Consultant to perform services for the Company, principally on behalf of SBI, and Consultant desires to perform such services, on the terms and conditions which are the subject of a Consulting Agreement for a period of time (the “Term of Engagement”) as more fully set forth in such Consulting Agreement. In addition to the compensation to which Consultant is already entitled, as a further inducement to the Company to engage Consultant as aforesaid, the parties hereto set forth the following additional terms and conditions.
 
2.           Consultant acknowledges that services to be provided by Consultant resulting from his knowledge of the business and his prior relationship with the Company, and the customers and competitors of the Company Group members, principally SBI, are unique and that obtaining or use of same by a competitive business or business similar to that of the Company or SBI would cause irreparable injury to the Company or SBI, as the case may be. Consultant covenants and agrees that:
 
(a)           From the date hereof through the date of termination of the Term of Engagement, Consultant will not, without the express written approval of the Board of Directors or the Chief Executive Officer of the Company, directly or indirectly, own, manage, operate, control, invest or acquire an interest in, or otherwise engage or participate in, or be associated with in any way, any business which competes directly or indirectly with the business or proposed business of a member of the Company Group (a "Competitive Business"); provided, however, that Consultant may, directly or indirectly, with his spouse own, invest or acquire an interest in the aggregate of up to two percent (2%) of the capital stock of a corporation whose capital stock is traded publicly.
 
(b)           Additionally, from the date hereof through the date which is 18 months after the date of termination of the Term of Engagement (the “Restricted Period”), Consultant will not, without the express written approval of the Board of Directors or the Chief Executive Officer of the Company, directly or indirectly, become associated with a Competitive Business, or otherwise engage in or assist in any enterprise, which develops, markets, sells, manufactures or designs products currently being sold, developed or contemplated, by a member of the Company Group, or which hereinafter may be sold, developed or contemplated, by a member of the Company Group, as of the date of termination of the Term of Engagement, including, but not limited to, catalytic research instruments; mixers, including vortex mixers, rotating, shaking or oscillating apparatus; thermoelectric apparatus; or any industrial or laboratory processes, apparatus or equipment relating thereto (the “Products”). Consultant may, during the Restricted Period, become associated with a Competitive Business to the extent association of the Consultant is not related in any way to the development, manufacture, design, marketing or sale of the Products or products which are intended to compete with the Products.
 
(c)           During the Restricted Period, Consultant will not, without the express prior written approval of the Board of Directors or Chief Executive Officer of the Company, (i) directly or indirectly, in one or a series of transactions, recruit, solicit or otherwise induce or influence any proprietor, partner, stockholder, lender, director, officer, employee, sales agent, joint venturer, investor, lessor, supplier, customer, consultant, agent, representative or any other person which has a business relationship with a member of the Company Group or to cause such person to discontinue, reduce or modify such employment, agency or business relationship with a member of the Company Group, or (ii) employ or seek to employ or cause any Competitive Business to employ or seek to employ any person or agent who is then (or was at any time within one (1) year prior to the date the Competitive Business employs or seeks to employ such person) engaged or retained by a member of the Company Group.
 
(d)           Since a breach of the provisions of this paragraph 2 could not adequately be compensated by money damages, the Company shall be entitled, in addition to any other right and remedy available to it, to an appropriate order from a court of competent jurisdiction restraining such breach or a threatened breach, and in any such case, no bond or other security shall be required to be posted in connection therewith, and Consultant hereby consents, to the issuance of such order. Consultant agrees that the provisions of this paragraph 2 are necessary and reasonable to protect the Company in the conduct of the business of the Company Group. If any restriction contained in this paragraph 2 shall be deemed to be invalid, illegal, or unenforceable by reason of the extent, duration, or geographical scope thereof, or otherwise, then the court making such determination shall have the right to reduce such extent, duration, geographical scope, or other provisions hereof, and in its reduced form such restriction shall then be enforceable in the manner contemplated hereby.
 
3.           Consultant agrees that from the date of this letter agreement and continuing indefinitely thereafter, Consultant shall not say or do anything which could disparage, undermine or be reasonably interpreted to denigrate the capabilities, performance, integrity or reputation of any member of the Company Group or any of its directors, officers, stockholders, agents, employees, representatives or consultants.
 
4.           Consultant agrees to indemnify and save the Company and its directors, officers, stockholders, agents, representatives, employees and consultants (and such persons' respective affiliates) harmless from any and all loss, damage, claims, liabilities, judgments and other cost and expense of every kind and nature which may be incurred by such persons by reason of the breach of any representation, warranty, covenant or agreement contained herein (including, without limitation, reasonable attorneys' fees and expenses), except in the case of such persons own willful default or gross negligence.
 
5.           The covenants, agreements, representations, and warranties contained in or made pursuant to this letter agreement shall survive the termination of the Term of Engagement, irrespective of any investigation made by or on behalf of any party.
 
6.           This letter agreement shall be deemed to have been made in the State of New York and shall be governed by and construed in accordance with the laws of the State of New York without regard to conflict of law rules thereof. Any action, suit or proceeding arising out of, or in connection with, this letter agreement shall be adjudicated in a court of competent jurisdiction located in Nassau or Suffolk County, State of New York. The parties hereto unconditionally waive any right to a trial by jury and any objection which either of them may now or hereafter have to the establishment of venue as aforementioned or that any action, suit or proceeding has been brought in an inconvenient forum. If you are in agreement with the foregoing, please execute two copies of this letter in the space provided below and return them to the undersigned.
 
 

 
 
 
Scientific Industries, Inc.
 
 
 
 
 

By:  
/s/ Helena R. Santos
 
 
 
Helena R. Santos 
 
 
 
President and Chief Executive Officer
 
 
 
 
 
 

ACCEPTED AND AGREED TO:
 

 
 
 

By:  
/s/ John A. Moore
 
 
 
John A. Moore